Roberttanser
69 posts
May 21, 2024
11:24 PM
|
Fildena 150 mg is a medication containing sildenafil citrate, which is the active ingredient in the well-known erectile dysfunction (ED) medication Viagra. Pfizer held the patent for Viagra, which covered sildenafil citrate, until 2013 in many countries. However, patents can vary by jurisdiction, and generic versions of sildenafil citrate have been available since then.
Typically, patents for medications are granted for a period of 20 years from the date of filing. After the expiration of the patent, other pharmaceutical companies can produce generic versions of the medication, leading to increased competition and potentially lower prices for consumers.
Since Viagra's patent expiration in various countries around 2013, generic versions of sildenafil citrate, including formulations similar to Fildena 150 Mg have been available on the market. Therefore, Fildena 150 mg itself may not be subject to a specific patent expiration date, as it is a generic formulation of sildenafil citrate.
However, it's essential to note that patent laws and regulations can vary by country, and the availability of generic versions of medications may differ accordingly.
|
